Kazumasa Yamamoto
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 16, 2026
Targeting claudin 18.2 in gastric cancer: a review of emerging biologic agents.Kazumasa Yamamoto, Izuma Nakayama, Kohei Shitara
|Dec 19, 2025
Durable Complete Response and Potential Cure With Systemic Chemotherapy in Metastatic Gastric Cancer: A Case Series of Patients.Shinpei Ushiyama, Takumi Habu, Izuma Nakayama
|Sep 23, 2025
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer.Fei Zhang, Izuma Nakayama, Naoya Sakamoto
|Sep 17, 2025
Association Between Immune-Related Adverse Events and Treatment Outcomes in Advanced Gastric Cancer Patients Receiving Nivolumab Plus Chemotherapy: A Retrospective Study.Kazumasa Yamamoto, Hidekazu Hirano, Toshiharu Hirose
|Aug 01, 2025
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological Factors.Amane Jubashi, Izuma Nakayama, Naoya Sakamoto
|Jun 19, 2025
Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyond.Kazumasa Yamamoto, Izuma Nakayama, Kohei Shitara
Pageof 1
Frequent Collaborators
5 joint publications
Izuma Nakayama
3 joint publications
Kohei Shitara
2 joint publications
Takahiro Kinoshita
2 joint publications
Yuki Matsubara
2 joint publications
Masahiro Yura
2 joint publications
Akihito Kawazoe
2 joint publications
Tadayoshi Hashimoto
2 joint publications
Takashi Kojima
2 joint publications
Yasutoshi Kuboki
2 joint publications
Hideaki Bando
